D89.832 Cytokine release syndrome, grade 2

Name of the Condition

• Cytokine release syndrome, grade 2

Summary

Cytokine release syndrome (CRS), grade 2, is a moderate form of an immune-mediated condition characterized by excessive cytokine release, leading to systemic inflammation and organ involvement. This grade typically presents with fever and mild to moderate hypotension, often requiring intervention. CRS can occur in response to infections, immunotherapies, or other immune-stimulating triggers, with severity graded based on clinical presentation.

Causes

CRS is triggered by overactivation of immune cells, which release large amounts of cytokines into the bloodstream. Common triggers include immunotherapies (e.g., chimeric antigen receptor T-cell therapy), infections, or medications that stimulate immune responses. The exact mechanism involves immune cell activation leading to a cytokine cascade, with grade 2 representing a moderate level of this response.

Risk Factors

• Exposure to immune-stimulating therapies (e.g., immunotherapy)
• Severe infections or sepsis
• Pre-existing immune dysregulation
• High cytokine levels from prior immune activation
• Certain genetic predispositions to inflammatory responses

Symptoms

• Fever and chills
• Moderate hypotension (low blood pressure)
• Tachycardia (rapid heart rate)
• Organ dysfunction (e.g., respiratory, renal)
• Fatigue and malaise

Diagnosis

Diagnosis of CRS, grade 2, involves clinical evaluation of symptoms (e.g., fever, hypotension) and exclusion of other causes. Laboratory tests may show elevated inflammatory markers (e.g., C-reactive protein, ferritin) and cytokine levels. Imaging or organ function tests may assess involvement of specific systems. Grading is based on symptom severity and need for intervention.

Treatment Options

Treatment focuses on managing symptoms and reducing cytokine release. Interventions may include fluids for hypotension, antipyretics for fever, and corticosteroids or other immunosuppressants in severe cases. Supportive care (e.g., oxygen, vasopressors) may be needed for organ dysfunction. Specific therapies target the underlying trigger (e.g., adjusting immunotherapy dosing).

Prognosis and Follow-Up

Prognosis for grade 2 CRS is generally favorable with prompt treatment, though progression to higher grades is possible. Follow-up includes monitoring for symptom resolution, organ function recovery, and recurrence. Long-term outcomes depend on the underlying trigger and response to therapy.

Complications

Complications may include progression to severe hypotension, respiratory failure, renal impairment, or multi-organ dysfunction. Delayed treatment or underlying comorbidities can increase risk of adverse outcomes.

Lifestyle & Prevention

Prevention focuses on managing triggers (e.g., careful monitoring during immunotherapy) and early intervention at symptom onset. Lifestyle measures include maintaining overall health to support immune function, though specific preventive strategies for CRS are limited.

When to Seek Professional Help

Seek immediate medical attention for persistent fever, worsening hypotension, or signs of organ dysfunction (e.g., shortness of breath, reduced urine output). Prompt evaluation is critical to prevent progression to higher-grade CRS.

Tips for Medical Coders

Document the clinical presentation (e.g., fever, hypotension) and any interventions (e.g., fluids, medications) to support grade 2 classification. Ensure documentation aligns with the ICD-10-CM definition of CRS, grade 2, and includes details on severity and management for accurate coding.